ANAVEX LIFE SCIENCES CORP. Quarterly Return On Assets in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Anavex Life Sciences Corp. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q2 2024.
  • Anavex Life Sciences Corp. Return On Assets for the quarter ending June 30, 2024 was -28.2 %, a 15.6% increase year-over-year.
  • Anavex Life Sciences Corp. annual Return On Assets for 2023 was -30.7 %, a 0.66% decline from 2022.
  • Anavex Life Sciences Corp. annual Return On Assets for 2022 was -30.5 %, a 6.42% increase from 2021.
  • Anavex Life Sciences Corp. annual Return On Assets for 2021 was -32.5 %, a 60.2% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -28.2 +5.2 +15.6% Apr 1, 2024 Jun 30, 2024
Q1 2024 -26.9 +7.15 +21% Jan 1, 2024 Mar 31, 2024
Q4 2023 -27.9 +4.35 +13.5% Oct 1, 2023 Dec 31, 2023
Q3 2023 -30.7 -0.2 -0.66% Jul 1, 2023 Sep 30, 2023
Q2 2023 -33.4 -5 -17.6% Apr 1, 2023 Jun 30, 2023
Q1 2023 -34 -7.2 -26.9% Jan 1, 2023 Mar 31, 2023
Q4 2022 -32.2 -3.42 -11.9% Oct 1, 2022 Dec 31, 2022
Q3 2022 -30.5 +2.09 +6.42% Jul 1, 2022 Sep 30, 2022
Q2 2022 -28.4 +9.53 +25.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 -26.8 +29 +52% Jan 1, 2022 Mar 31, 2022
Q4 2021 -28.8 +43.9 +60.4% Oct 1, 2021 Dec 31, 2021
Q3 2021 -32.5 +49.2 +60.2% Jul 1, 2021 Sep 30, 2021
Q2 2021 -38 +48.9 +56.3% Apr 1, 2021 Jun 30, 2021
Q1 2021 -55.8 +38.8 +41% Jan 1, 2021 Mar 31, 2021
Q4 2020 -72.7 +31.9 +30.5% Oct 1, 2020 Dec 31, 2020
Q3 2020 -81.7 +35.2 +30.1% Jul 1, 2020 Sep 30, 2020
Q2 2020 -86.8 +28.9 +25% Apr 1, 2020 Jun 30, 2020
Q1 2020 -94.6 -0.06 -0.06% Jan 1, 2020 Mar 31, 2020
Q4 2019 -105 -25 -31.3% Oct 1, 2019 Dec 31, 2019
Q3 2019 -117 -52.6 -81.7% Jul 1, 2019 Sep 30, 2019
Q2 2019 -116 -54 -87.4% Apr 1, 2019 Jun 30, 2019
Q1 2019 -94.6 -28.8 -43.9% Jan 1, 2019 Mar 31, 2019
Q4 2018 -79.7 -24.8 -45.1% Oct 1, 2018 Dec 31, 2018
Q3 2018 -64.4 -9.26 -16.8% Jul 1, 2018 Sep 30, 2018
Q2 2018 -61.8 +12.9 +17.3% Apr 1, 2018 Jun 30, 2018
Q1 2018 -65.7 +17.9 +21.4% Jan 1, 2018 Mar 31, 2018
Q4 2017 -54.9 +50.5 +47.9% Oct 1, 2017 Dec 31, 2017
Q3 2017 -55.1 +74.5 +57.5% Jul 1, 2017 Sep 30, 2017
Q2 2017 -74.7 +30.9 +29.3% Apr 1, 2017 Jun 30, 2017
Q1 2017 -83.6 +42.1 +33.5% Jan 1, 2017 Mar 31, 2017
Q4 2016 -105 +33.9 +24.3% Oct 1, 2016 Dec 31, 2016
Q3 2016 -130 +1.78 +1.36% Jul 1, 2016 Sep 30, 2016
Q2 2016 -106 +104 +49.6% Apr 1, 2016 Jun 30, 2016
Q1 2016 -126 +31.5 +20% Jan 1, 2016 Mar 31, 2016
Q4 2015 -139 -8.68 -6.64% Oct 1, 2015 Dec 31, 2015
Q3 2015 -131 +15.7 +10.7% Jul 1, 2015 Sep 30, 2015
Q2 2015 -209 -117 -126% Apr 1, 2015 Jun 30, 2015
Q1 2015 -157 -16.9 -12.1% Jan 1, 2015 Mar 31, 2015
Q4 2014 -131 +1.98K +93.8% Oct 1, 2014 Dec 31, 2014
Q3 2014 -147 +2.95K +95.3% Jul 1, 2014 Sep 30, 2014
Q2 2014 -92.5 +5.62K +98.4% Apr 1, 2014 Jun 30, 2014
Q1 2014 -140 -36.3 -34.9% Jan 1, 2014 Mar 31, 2014
Q4 2013 -2.11K -1.99K -1694% Oct 1, 2013 Dec 31, 2013
Q3 2013 -3.1K -2.95K -1994% Jul 1, 2013 Sep 30, 2013
Q2 2013 -5.71K -5.55K -3301% Apr 1, 2013 Jun 30, 2013
Q1 2013 -104 +1.38K +93% Jan 1, 2013 Mar 31, 2013
Q4 2012 -117 Oct 1, 2012 Dec 31, 2012
Q3 2012 -148 Jul 1, 2012 Sep 30, 2012
Q2 2012 -168 Apr 1, 2012 Jun 30, 2012
Q1 2012 -1.49K Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.